Dosimetry: The next frontier

Sunday, March 5, 2023

8:30 AM – 10:00 AM

Location:Phoenix Convention Center, 228AB

CE: 1.5 Credits

Coordinator(s)

Shamar Young, MD

Associate professor and Chief of Interventional Radiology
University of Arizona

Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)
Nima Kokabi, MD

Assistant Professor of Radiology
Emory School of Medicine

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Shamar Young, MD: Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

Nima Kokabi, MD: No financial relationships to disclose

This session will review the advancements in dosimetry for radioembolization which have been made over the last several years. It will also discuss current challenges and future directions.

Learning Objectives:

To understand the current evidence on dose thresholds for hepatocellular carcinoma paitents undergoing transarterial radioembolization
To gain knowledge on what is known, and remains unknown, in regards to normal tissue toxicity
To understand available evidence on dose thresholds for non-HCC patients and areas requiring further investigation.

Presentations:

8:30 AM – 8:43 AM

Normal tissue dosing, a waist of time or integral treatment tool
Speaker: Shamar Young, MD – University of Arizona
8:43 AM – 8:56 AM

Y90 surrogates: Is Tc-MAA the best we can do?
Speaker: Nima Kokabi, MD – Emory School of Medicine
8:56 AM – 9:09 AM

Dosimetry in HCC: What do we know, what can we still learn
Speaker: Nima Kokabi, MD – Emory School of Medicine
Speaker: Shamar Young, MD – University of Arizona
9:09 AM – 9:22 AM

Dosimetry in mCRC: How do I maximize outcomes?
Speaker: Armeen Mahvash, MD – MD Anderson Cancer Center
9:22 AM – 9:35 AM

Dosimetry in cancers where data doesn't exist, what do I do?
Speaker: Siddharth Padia, MD, FSIR – UCLA
9:35 AM – 9:48 AM

Dosimetry: Future directions and areas of research focus.
Speaker: Beau B. Toskich, MD, FSIR – Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States
9:48 AM – 10:00 AM

Q & A